Loading…
Pharmaceuticals in Australia: developments in regulation and governance
The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern o...
Saved in:
| Published in: | Social science & medicine (1982) 2004-06, Vol.58 (12), p.2397-2407 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913 |
| container_end_page | 2407 |
| container_issue | 12 |
| container_start_page | 2397 |
| container_title | Social science & medicine (1982) |
| container_volume | 58 |
| creator | Lofgren, Hans Boer, Rebecca de |
| description | The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business. |
| doi_str_mv | 10.1016/j.socscimed.2003.09.012 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71831385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0277953603004829</els_id><sourcerecordid>60668505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhhtR3HH1L2gj6G3Gylcn7W1YdBVW9KDnkEmqdzP0l0n3wP57q51hEC9zSALJ8xZVeYriDYMNA1Z92G_y4LOPHYYNBxAbqDfA-JNixYwWayWkflqsgGu9rpWorooXOe8BgIERz4srpsAwVvNVcfvjwaXOeZyn6F2by9iX2zlPybXRfSwDHrAdxg776e9Twvu5dVMc-tL1obwfDph613t8WTxrKI6vTud18evzp583X9Z332-_3mzv1l6palo7E3jFa2akU6qWqqnAcK2Q8Z1ytUPkEkQQQfuwC5zpRgrOPBolICDlxHXx_lh3TMPvGfNku5g9tq3rcZiz1cwIJoi_BFZQVUbBZVBppqUwFYFv_wP3w0zTt9lyAdJIxYEgfYR8GnJO2Ngxxc6lR8vALurs3p7V2UWdhdqSOkp-OyYTjujPMUQkfoEPVjhlaHukRUlJR6TFOG3jcidqbekDtX2YOqr3-tTuvFvi5z5O7gl4dwJcJvVNIo8x_8NVUmi5zL09ckheDxGTpe6RnIeY0E82DPHicH8AsgnTkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230484520</pqid></control><display><type>article</type><title>Pharmaceuticals in Australia: developments in regulation and governance</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>International Bibliography of the Social Sciences (IBSS)</source><source>ScienceDirect Freedom Collection 2022-2024</source><source>Worldwide Political Science Abstracts</source><source>Sociological Abstracts</source><creator>Lofgren, Hans ; Boer, Rebecca de</creator><creatorcontrib>Lofgren, Hans ; Boer, Rebecca de</creatorcontrib><description>The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business.</description><identifier>ISSN: 0277-9536</identifier><identifier>EISSN: 1873-5347</identifier><identifier>DOI: 10.1016/j.socscimed.2003.09.012</identifier><identifier>PMID: 15081192</identifier><identifier>CODEN: SSMDEP</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Australia ; Australia Health policy Networks Partnerships Pharmaceutical industry Politics Regulation ; Biological and medical sciences ; Drug Approval ; Drug industry ; Drug Industry - organization & administration ; Drugs ; Ethics ; Governance ; Government Regulation ; Health care networks ; Health care policy ; Health Care Surveys ; Health Policy ; Humans ; Industry ; Insurance, Pharmaceutical Services ; Medical sciences ; Medications ; National Health Programs - legislation & jurisprudence ; Networks ; Organizational Innovation ; Partnering ; Partnerships ; Pharmaceutical industry ; Policy Making ; Politics ; Prescriptions ; Program Development ; Program Evaluation ; Regulation ; Surveys and Questionnaires ; Technology, Pharmaceutical</subject><ispartof>Social science & medicine (1982), 2004-06, Vol.58 (12), p.2397-2407</ispartof><rights>2003 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Pergamon Press Inc. Jun 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913</citedby><cites>FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,31000,33223,33774</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15643746$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15081192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://econpapers.repec.org/article/eeesocmed/v_3a58_3ay_3a2004_3ai_3a12_3ap_3a2397-2407.htm$$DView record in RePEc$$Hfree_for_read</backlink></links><search><creatorcontrib>Lofgren, Hans</creatorcontrib><creatorcontrib>Boer, Rebecca de</creatorcontrib><title>Pharmaceuticals in Australia: developments in regulation and governance</title><title>Social science & medicine (1982)</title><addtitle>Soc Sci Med</addtitle><description>The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business.</description><subject>Australia</subject><subject>Australia Health policy Networks Partnerships Pharmaceutical industry Politics Regulation</subject><subject>Biological and medical sciences</subject><subject>Drug Approval</subject><subject>Drug industry</subject><subject>Drug Industry - organization & administration</subject><subject>Drugs</subject><subject>Ethics</subject><subject>Governance</subject><subject>Government Regulation</subject><subject>Health care networks</subject><subject>Health care policy</subject><subject>Health Care Surveys</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Industry</subject><subject>Insurance, Pharmaceutical Services</subject><subject>Medical sciences</subject><subject>Medications</subject><subject>National Health Programs - legislation & jurisprudence</subject><subject>Networks</subject><subject>Organizational Innovation</subject><subject>Partnering</subject><subject>Partnerships</subject><subject>Pharmaceutical industry</subject><subject>Policy Making</subject><subject>Politics</subject><subject>Prescriptions</subject><subject>Program Development</subject><subject>Program Evaluation</subject><subject>Regulation</subject><subject>Surveys and Questionnaires</subject><subject>Technology, Pharmaceutical</subject><issn>0277-9536</issn><issn>1873-5347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>8BJ</sourceid><sourceid>BHHNA</sourceid><sourceid>7QJ</sourceid><sourceid>7UB</sourceid><recordid>eNqFkU2LFDEQhhtR3HH1L2gj6G3Gylcn7W1YdBVW9KDnkEmqdzP0l0n3wP57q51hEC9zSALJ8xZVeYriDYMNA1Z92G_y4LOPHYYNBxAbqDfA-JNixYwWayWkflqsgGu9rpWorooXOe8BgIERz4srpsAwVvNVcfvjwaXOeZyn6F2by9iX2zlPybXRfSwDHrAdxg776e9Twvu5dVMc-tL1obwfDph613t8WTxrKI6vTud18evzp583X9Z332-_3mzv1l6palo7E3jFa2akU6qWqqnAcK2Q8Z1ytUPkEkQQQfuwC5zpRgrOPBolICDlxHXx_lh3TMPvGfNku5g9tq3rcZiz1cwIJoi_BFZQVUbBZVBppqUwFYFv_wP3w0zTt9lyAdJIxYEgfYR8GnJO2Ngxxc6lR8vALurs3p7V2UWdhdqSOkp-OyYTjujPMUQkfoEPVjhlaHukRUlJR6TFOG3jcidqbekDtX2YOqr3-tTuvFvi5z5O7gl4dwJcJvVNIo8x_8NVUmi5zL09ckheDxGTpe6RnIeY0E82DPHicH8AsgnTkQ</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Lofgren, Hans</creator><creator>Boer, Rebecca de</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Pergamon Press Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>DKI</scope><scope>X2L</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U3</scope><scope>7U4</scope><scope>8BJ</scope><scope>BHHNA</scope><scope>DWI</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>WZK</scope><scope>7QJ</scope><scope>7UB</scope><scope>7X8</scope></search><sort><creationdate>20040601</creationdate><title>Pharmaceuticals in Australia: developments in regulation and governance</title><author>Lofgren, Hans ; Boer, Rebecca de</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Australia</topic><topic>Australia Health policy Networks Partnerships Pharmaceutical industry Politics Regulation</topic><topic>Biological and medical sciences</topic><topic>Drug Approval</topic><topic>Drug industry</topic><topic>Drug Industry - organization & administration</topic><topic>Drugs</topic><topic>Ethics</topic><topic>Governance</topic><topic>Government Regulation</topic><topic>Health care networks</topic><topic>Health care policy</topic><topic>Health Care Surveys</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Industry</topic><topic>Insurance, Pharmaceutical Services</topic><topic>Medical sciences</topic><topic>Medications</topic><topic>National Health Programs - legislation & jurisprudence</topic><topic>Networks</topic><topic>Organizational Innovation</topic><topic>Partnering</topic><topic>Partnerships</topic><topic>Pharmaceutical industry</topic><topic>Policy Making</topic><topic>Politics</topic><topic>Prescriptions</topic><topic>Program Development</topic><topic>Program Evaluation</topic><topic>Regulation</topic><topic>Surveys and Questionnaires</topic><topic>Technology, Pharmaceutical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lofgren, Hans</creatorcontrib><creatorcontrib>Boer, Rebecca de</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>RePEc IDEAS</collection><collection>RePEc</collection><collection>CrossRef</collection><collection>Social Services Abstracts</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Sociological Abstracts (Ovid)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Worldwide Political Science Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Social science & medicine (1982)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lofgren, Hans</au><au>Boer, Rebecca de</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmaceuticals in Australia: developments in regulation and governance</atitle><jtitle>Social science & medicine (1982)</jtitle><addtitle>Soc Sci Med</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>58</volume><issue>12</issue><spage>2397</spage><epage>2407</epage><pages>2397-2407</pages><issn>0277-9536</issn><eissn>1873-5347</eissn><coden>SSMDEP</coden><abstract>The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15081192</pmid><doi>10.1016/j.socscimed.2003.09.012</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0277-9536 |
| ispartof | Social science & medicine (1982), 2004-06, Vol.58 (12), p.2397-2407 |
| issn | 0277-9536 1873-5347 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71831385 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); International Bibliography of the Social Sciences (IBSS); ScienceDirect Freedom Collection 2022-2024; Worldwide Political Science Abstracts; Sociological Abstracts |
| subjects | Australia Australia Health policy Networks Partnerships Pharmaceutical industry Politics Regulation Biological and medical sciences Drug Approval Drug industry Drug Industry - organization & administration Drugs Ethics Governance Government Regulation Health care networks Health care policy Health Care Surveys Health Policy Humans Industry Insurance, Pharmaceutical Services Medical sciences Medications National Health Programs - legislation & jurisprudence Networks Organizational Innovation Partnering Partnerships Pharmaceutical industry Policy Making Politics Prescriptions Program Development Program Evaluation Regulation Surveys and Questionnaires Technology, Pharmaceutical |
| title | Pharmaceuticals in Australia: developments in regulation and governance |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A34%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmaceuticals%20in%20Australia:%20developments%20in%20regulation%20and%20governance&rft.jtitle=Social%20science%20&%20medicine%20(1982)&rft.au=Lofgren,%20Hans&rft.date=2004-06-01&rft.volume=58&rft.issue=12&rft.spage=2397&rft.epage=2407&rft.pages=2397-2407&rft.issn=0277-9536&rft.eissn=1873-5347&rft.coden=SSMDEP&rft_id=info:doi/10.1016/j.socscimed.2003.09.012&rft_dat=%3Cproquest_cross%3E60668505%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c556t-a8d2629184a55945f608275e12b5a9aee2403d3d7cdbd217f4321ce8530de2913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230484520&rft_id=info:pmid/15081192&rfr_iscdi=true |